EU regulator reviews AstraZeneca vaccine

LONDON: The world awaits a decision from Europe’s top medical regulator into whether there is any evidence to show the AstraZeneca coronavirus vaccine is linked to a small number of blood clots reported in people across the continent.
The European Medicines Agency’s expert committee is set to announce the results of its investigation later on Thursday.